Previous 10 | Next 10 |
home / stock / biovf / biovf news
2023-10-30 12:17:25 ET More on Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB (publ) 2023 Q3 - Results - Earnings Call Presentation Apellis extends selloff as JPMorgan becomes latest to downgrade Historical earnings data for Swedish Orphan Biovitrum AB ...
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Swedish Orphan Biovitrum AB (BIOVF) is expected to report $0.09 for Q3 2023
2023-08-03 10:40:25 ET More on Apellis Pharmaceuticals Apellis: Exercise Caution In Response To Safety Signal (Rating Downgrade) Apellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition Space Apellis off 18% despite reassurance of safety of vision drug, earnin...
2023-07-18 16:45:19 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2023 Results Conference Call July 18, 2023 07:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Armin Reininger - Senior Scientific...
2023-07-18 08:24:42 ET Swedish Orphan Biovitrum AB press release ( OTCPK:BIOVF ): Q2 Non-GAAP EPS of SEK1.48. Revenue of SEK4.87B (+25.8% Y/Y) misses by $419.36M . For further details see: Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK1.48, revenue of SEK4.87M m...
2023-05-10 10:51:53 ET Shares of CTI BioPharma (NASDAQ: CTIC) were up more than 80% early Wednesday after the company announced it was getting bought out for $1.7 billion by Swedish Orphan Biovitrum AB (OTC: BIOVF) , also known as SOBI. CTI BioPharma specializes in targe...
2023-04-29 10:58:09 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2023 Earnings Conference Call April 27, 2023 8:00 a.m. ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Tony Hoos - Head of RDMA, Chief ...
2023-04-29 10:34:32 ET The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2023 Q1 earnings call. For further details see: Swedish Orphan Biovitrum AB (publ) 2023 Q1 - Results - Earnings Call Presentation
2023-04-27 12:54:50 ET Swedish Orphan Biovitrum AB press release ( OTCPK:BIOVF ): Q1 Non-GAAP EPS of SEK3.60. Revenue of SEK5.24M. For further details see: Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK3.60, revenue of SEK5.24M
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of three abstracts that highlights data from its myelofibrosis treatment option at the American Society of Clin...
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to emapalumab-lzsg being investigated as a pot...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...